Literature DB >> 19309308

Association of interleukin-18 gene promoter polymorphisms with risk of acute myocardial infarction in northern Chinese Han population.

Fang Pei1, Yaling Han, Xiaolin Zhang, Chenghui Yan, Mingfang Huang, Lan Huang, Jian Kang.   

Abstract

BACKGROUND: Interleukin-18 (IL-18) has been suggested to play an important role in coronary arterial disease and its sequelae. The aim of the present study was to investigate the association between IL-18 promoter functional polymorphisms (-607C/A and -137G/C) and acute myocardial infarction (AMI) in northern Chinese Han population.
METHODS: We performed a case-control study including 234 patients with AMI and 216 age- and sex-matched controls. Genotyping was performed using sequence specific primer-polymerase chain reaction (PCR-SSP).
RESULTS: There were significant differences in the genotype and allele distribution of -607C/A polymorphism of the IL-18 gene between cases and controls. Logistic regression analysis with adjustments for other well-established risk factors revealed that the -607C allele carriers had a significantly increased risk of AMI compared with the non-carriers (OR=1.890, 95% CI 1.196-2.985, p=0.006). No relationship between -137G/C polymorphism and AMI was found.
CONCLUSIONS: This study shows for the first time that the IL-18 gene promoter -607C/A polymorphism may be considered a genetic risk factor for AMI in northern Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19309308     DOI: 10.1515/CCLM.2009.130

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Increased IL18 mRNA levels in peripheral artery disease and its association with triglyceride and LDL cholesterol levels: a pilot study.

Authors:  Serkan Burc Deser; Burcu Bayoglu; Kazım Besirli; Mujgan Cengiz; Berk Arapi; Yerik Junusbekov; Ahmet Dirican; Caner Arslan
Journal:  Heart Vessels       Date:  2015-10-05       Impact factor: 2.037

Review 2.  Interleukin 18 and coronary heart disease: prospective study and systematic review.

Authors:  Barbara J M H Jefferis; Olia Papacosta; Christopher G Owen; S Goya Wannamethee; Steve E Humphries; Mark Woodward; Lucy T Lennon; Andrew Thomson; Paul Welsh; Ann Rumley; Gordon D O Lowe; Peter H Whincup
Journal:  Atherosclerosis       Date:  2011-03-24       Impact factor: 5.162

3.  Correlation between interleukin-18 promoter -607C/A polymorphism and susceptibility to ischemic stroke.

Authors:  Jian-xia Lu; Zhong-qian Lu; Shao-lan Zhang; Juan Zhi; Zheng-ping Chen; Wan-xiang Wang
Journal:  Braz J Med Biol Res       Date:  2013-05-24       Impact factor: 2.590

4.  Polymorphism of C3 complement in association with myocardial infarction in a sample of central Tunisia.

Authors:  Nadia Leban; Karim Jraba; Abdelkader Chalghoum; Selma Hassine; Donia Elhayek; Sabri Denden; Ramzi Lakhdhar; Faouzi Maatoug; Habib Gamra; Hammadi Braham; Jemni Ben Chibani; Amel Haj Khelil
Journal:  Diagn Pathol       Date:  2013-06-13       Impact factor: 2.644

5.  Association between polymorphisms in interleukin-18 promoter and risk of coronary artery disease: a meta-analysis.

Authors:  Zheng Lian; Su-Fang Li; Yu-Xia Cui; Man-Yan Wu; Li-Na Su; Dan Hu; Wei-Jue Xiong; Hong Chen
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

6.  No association between interleukin-18 levels and risk of cardiovascular disease: A Mendelian randomization study.

Authors:  Siyu Fan; Pan He; Jieqiong Guan; Wenjing Song; Hong Zhi; Lina Wang
Journal:  Hereditas       Date:  2020-04-07       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.